| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.23B | 16.04B | 13.85B | 11.70B | 10.20B | 10.53B |
| Gross Profit | 7.54B | 7.19B | 6.21B | 4.69B | 3.94B | 4.30B |
| EBITDA | 4.41B | 4.22B | 3.17B | 1.83B | 1.61B | 1.72B |
| Net Income | 2.63B | 2.50B | 2.07B | 1.04B | 877.54M | 960.14M |
Balance Sheet | ||||||
| Total Assets | 22.90B | 22.21B | 20.17B | 17.68B | 15.17B | 12.93B |
| Cash, Cash Equivalents and Short-Term Investments | 1.80B | 1.60B | 1.72B | 1.34B | 2.25B | 2.34B |
| Total Debt | 5.09B | 4.56B | 4.47B | 4.40B | 3.38B | 2.29B |
| Total Liabilities | 10.87B | 10.44B | 10.52B | 9.92B | 8.19B | 6.55B |
| Stockholders Equity | 12.03B | 11.76B | 9.65B | 7.75B | 6.97B | 6.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 373.25M | 507.08M | -1.65B | -1.23B | 48.23M |
| Operating Cash Flow | 0.00 | 2.24B | 2.00B | 548.27M | 233.60M | 1.82B |
| Investing Cash Flow | 0.00 | -2.00B | -1.50B | -2.19B | -1.08B | -1.73B |
| Financing Cash Flow | 0.00 | -364.45M | -118.20M | 733.82M | 750.74M | 1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥124.63B | 7.55 | ― | 1.61% | 5.13% | 72.55% | |
78 Outperform | ¥45.08B | 12.45 | ― | 0.95% | 22.70% | 47.27% | |
77 Outperform | ¥256.38B | 13.32 | ― | 1.53% | 9.71% | 54.82% | |
76 Outperform | ¥1.88T | 7.87 | 12.05% | 1.50% | 9.27% | 3.50% | |
72 Outperform | ¥52.12B | 12.37 | ― | 0.91% | 8.50% | 14.99% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥52.52B | -60.12 | ― | 5.01% | -25.54% | -166.77% |